Lara Gerhardt

Lara Gerhardt

Auto-generated profile, based on publicly available information

Lara Gerhardt

Cancer Research Laboratory Program, Lawson Health Research Institute, London, ON N6A5 W9, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
MKMithunah Krishnamoorthy
Mithunah Krishnamoorthy
LGLara Gerhardt
Lara Gerhardt
SVSaman Maleki Vareki
Saman Maleki Vareki
The primary function of myeloid cells is to protect the host from infections. However, during cancer progression or states of chronic inflammation, these cells develop into myeloid-derived suppressor cells (MDSCs) that play a prominent role in suppressing anti-tumor immunity. Overcoming the suppressive effects of MDSCs is a major hurdle in cancer immunotherapy. Therefore, understanding the mechanisms by which MDSCs promote tumor growth is essential for improving current immunotherapies and developing new ones. This review explores mechanisms by which MDSCs suppress T-cell immunity and how this impacts the efficacy of commonly used immunotherapies.